Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:01 UTC |
Berkowitz NoahChief Medical Officer
|
GrantPerformance Stock Units · Derivative | 135,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 3 Berkowitz Noah · CIK 0001369900 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Underlying: Common stock · 135,000 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock. F4 · shares: Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones. F5 · derivative.exercise_date: Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones. F5 · derivative.expiration_date: Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:01 UTC |
Berkowitz NoahChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 180,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 2 Berkowitz Noah · CIK 0001369900 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common stock · 180,000 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F1 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| September 30, 2026 Filed Oct 3, 2026 01:01 UTC |
Berkowitz NoahChief Medical Officer
|
GrantStock Options (Right to Buy) · Derivative | 135,000 | $0.00 Strike: $14.82 | $0.00 |
DisclosureSEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 1 Berkowitz Noah · CIK 0001369900 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,000 Underlying: Common stock · 135,000 shares Expires 2036-09-30 F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 15,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,756 Underlying: Common stock · 15,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 6,638 | $8.70 | $57,750.60 |
DisclosureSEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,447 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:01 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 15,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 602,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,878 Underlying: Common stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 3,976 | $8.70 | $34,591.20 |
DisclosureSEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,074 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,050 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,599 Underlying: Common stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 4,478 | $8.70 | $38,958.60 |
DisclosureSEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 256,364 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 41,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,338 Underlying: Common stock · 41,669 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 17,702 | $8.28 | $146,572.56 |
DisclosureSEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 586,459 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 41,669 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 604,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,939 Underlying: Common stock · 5,470 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 2,508 | $8.28 | $20,766.24 |
DisclosureSEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,076 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:02 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 5,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,580 Underlying: Common stock · 8,789 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 4,472 | $8.28 | $37,028.16 |
DisclosureSEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,237 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 8,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 21:30 UTC |
Kirby Daniel GordonChief Commercial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · derivative · entry 3 Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,003 Underlying: Common Stock · 10,001 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 21:30 UTC |
Kirby Daniel GordonChief Commercial Officer
|
Tax withholdingCommon Stock | 2,436 | $6.40 | $15,590.40 |
DisclosureSEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · nonDerivative · entry 2 Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,511 F2 · date: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 21:30 UTC |
Kirby Daniel GordonChief Commercial Officer
|
Exercise / conversionCommon Stock | 10,001 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · nonDerivative · entry 1 Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 21:30 UTC |
Roche Corleen M.Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 49,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · derivative · entry 3 Roche Corleen M. · CIK 0001857905 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,005 Underlying: Common Stock · 49,995 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on August 6, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 21:30 UTC |
Roche Corleen M.Chief Financial Officer
|
Tax withholdingCommon Stock | 21,238 | $6.21 | $131,887.98 |
DisclosureSEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · nonDerivative · entry 2 Roche Corleen M. · CIK 0001857905 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,757 F2 · date: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 21:30 UTC |
Roche Corleen M.Chief Financial Officer
|
Exercise / conversionCommon Stock | 49,995 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · nonDerivative · entry 1 Roche Corleen M. · CIK 0001857905 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,995 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:15 UTC |
Puri Raj K.Chief Regulatory Officer
|
GrantRestricted Stock Units · Derivative | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075854 · tm2618145-1_4seq1.xml · derivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common stock · 15,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:17 UTC |
WEISER MICHAELDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 90,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075863 · tm2618145-5_4seq1.xml · derivative · entry 1 WEISER MICHAEL · CIK 0001221449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,316 Underlying: Common Stock · 90,316 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:15 UTC |
Maynard Ryan DDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 90,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075856 · tm2618145-2_4seq1.xml · derivative · entry 1 Maynard Ryan D · CIK 0001363984 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,316 Underlying: Common Stock · 90,316 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:16 UTC |
Dukes Iain D.Director
|
GrantDeferred Restricted Stock Unit · Derivative | 180,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075861 · tm2618145-4_4seq1.xml · derivative · entry 1 Dukes Iain D. · CIK 0001681955 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,632 Underlying: Common Stock · 180,632 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 21:16 UTC |
Countouriotis AthenaDirector
|
GrantDeferred Restricted Stock Unit · Derivative | 90,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-075858 · tm2618145-3_4seq1.xml · derivative · entry 1 Countouriotis Athena · CIK 0001571469 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,316 Underlying: Common Stock · 90,316 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended). F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,365 Underlying: Common stock · 9,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 3,843 | $4.23 | $16,255.89 |
DisclosureSEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,114 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 9,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:01 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,691 Underlying: Common stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:01 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 3,976 | $4.23 | $16,818.48 |
DisclosureSEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,111 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:01 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:03 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · derivative · entry 3 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,382 Underlying: Common stock · 15,625 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:03 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Tax withholdingCommon Stock | 6,638 | $4.23 | $28,078.74 |
DisclosureSEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · nonDerivative · entry 2 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 562,492 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 17:03 UTC |
Vogt Frederick GDirector · Interim CEO & General Counsel
|
Exercise / conversionCommon Stock | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · nonDerivative · entry 1 Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 569,130 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · derivative · entry 3 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,691 Underlying: Common stock · 7,813 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Tax withholdingCommon Stock | 3,976 | $4.23 | $16,818.48 |
DisclosureSEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · nonDerivative · entry 2 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,920 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:00 UTC |
BILINSKY IGORChief Operating Officer
|
Exercise / conversionCommon Stock | 7,813 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · nonDerivative · entry 1 BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:01 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · derivative · entry 3 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,409 Underlying: Common stock · 5,469 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:01 UTC |
Puri Raj K.Chief Regulatory Officer
|
Tax withholdingCommon Stock | 2,508 | $3.96 | $9,931.68 |
DisclosureSEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · nonDerivative · entry 2 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,191 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:01 UTC |
Puri Raj K.Chief Regulatory Officer
|
Exercise / conversionCommon Stock | 5,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · nonDerivative · entry 1 Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 244,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 8,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · derivative · entry 3 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,369 Underlying: Common stock · 8,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments. F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments. F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Tax withholdingCommon Stock | 4,473 | $3.96 | $17,713.08 |
DisclosureSEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · nonDerivative · entry 2 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,274 F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:00 UTC |
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
|
Exercise / conversionCommon Stock | 8,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · nonDerivative · entry 1 GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.